Solventum has grown revenue 0.79% a year over three years and 0.79% a year over five, with earnings per share compounding at 4.5%. Revenue growth, 3-year annual rate: +0.79% (Medical Instruments & Supplies median +10%). Revenue growth, 5-year rate: +0.79%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +4.5%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 4, FY2022 to FY2025, as filed.

SOLVSolventum

HealthcareUSD

$91.53

$62.4952 weeks$91.60

Is it growing?

Is SOLV growing?

Solventum has grown revenue 0.79% a year over three years and 0.79% a year over five, with earnings per share compounding at 4.5%.

+0.79%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +10% · growing slowly · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +0.79%
Revenue growth, 5-year rate · +0.79% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +4.5%
Earnings per share, 3-year rate · revenue +0.79% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 4
Years of annual history on file · FY2022 to FY2025, as filed